PI reaction very scary
Mar 21, 2005
My doctor changed my meds to 1400mg/day of Lexiva and 200mg/day of Norvir to boost it. He also included 300 mg of Epzicom. Within 9 days of this new cocktail I had joint and muscle pain and a severe rash over 90% of my body. He advised me to drop the Norvir, but continue on the remaining drugs. What in your opinion should I continue to take or not take. I am PI naive and this has really frightened me. Should I ask to not be on any PI's?
Thank you for your opinion
Response from Dr. Henry
Both the fosamprenavir (Lexiva) and the abacavir (in Epzicom) can cause rashes (usually the Norvir doesn't contribute) which can be hard to sort out and is one reason I don't favor starting those drugs together at the same time im most cases. The abacavir can cause a serious hypersensitivity reaction which can include a rash so other symptoms need to be carefully evaluated. If you have previously failed other medications especially a PI then stopping the Norivir is often not advisable. Your HIV specialist usually is the best person to advise you as to the best course of action. KH
Get Email Notifications When This Forum Updates or Subscribe With RSS
- Are Swollen Lymph Nodes A Sign Of HIV?
- Purple Spots Could I Have AIDS
- Chances Of Catching HIV From Blowjob From A Prostitute
- Blood In Urine After Receptive Anal Sex With Condom Does It Mean I Have HIV
- Flu Symptoms After Swallowing Cum Worried I Have HIV
- Groin Pain After Vaginal Sex Without Condom Does It Mean I Have HIV
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.